Earnings Scheduled For May 5, 2022
Companies Reporting Before The Bell
• Mirum Pharmaceuticals (NASDAQ:MIRM) is expected to report quarterly loss at $1.34 per share on revenue of $8.46 million.
Where Cognex Stands With Analysts
Cognex (NASDAQ:CGNX) has observed the following analyst ratings within the last quarter:
Goldman Sachs Maintains Sell on Cognex, Lowers Price Target to $67
Goldman Sachs maintains Cognex (NASDAQ:CGNX) with a Sell and lowers the price target from $77 to $67.
42 Stocks Moving In Friday’s Mid-Day Session
Gainers
Fast Radius, Inc. (NASDAQ: FSRD) shares jumped 72.6% to $6.56 after jumping 17% on Thursday.
Looking Into Cognex’s Return On Capital Employed
Pulled from Benzinga Pro data, Cognex (NASDAQ:CGNX) posted Q4 earnings of $53.53 million, an increase from Q3 of 32.15%. Sales dropped to $244.06 million, a 14.32% decrease between quarters.
Morgan Stanley Maintains Equal-Weight on Cognex, Lowers Price Target to $75
Morgan Stanley analyst Joshua Pokrzywinski maintains Cognex (NASDAQ:CGNX) with a Equal-Weight and lowers the price target from $83 to $75.
26 Stocks Moving in Friday’s Pre-Market Session
Gainers
Energy Vault Holdings, Inc. (NYSE: NRGV) rose 34.2% to $14.90 in pre-market trading after jumping around 14% on Thursday. Energy Vault Holdings recently started trading on the New York Stock Exchange.
JP Morgan Upgrades Cognex to Neutral, Lowers Price Target to $68
JP Morgan analyst Paul Chung upgrades Cognex (NASDAQ:CGNX) from Underweight to Neutral and lowers the price target from $80 to $68.
Benzinga’s After-Hours Earnings Roundup: Roku, Shake Shack, Dropbox And More
Benzinga’s after-hours earnings roundup aims to deliver quick details about a company's earnings report, its forward-looking guidance and any other notable details.
The list is handpicked by the reporters on the Benzinga Pro Newsdesk team.